Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression

Clinica Chimica Acta

Volumn 424, Issue , 2013, Pages 175-181

  Huang, Tiao Lai ^a   Cho, Yi Tzu ^b   Su, Hong ^c   Shiea, Jentaie ^c,d  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Yuh Ing Junior College of Health Care and Management   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acid hydrolysis; Major depression; Matrix assisted laser desorption ionization time of flight mass spectrometry; Principle component analysis; Protein biomarker

Indexed keywords

CARBOXYLIC ACID; FIBRINOGEN; SINAPIC ACID; TRANSFERRIN; TRIFLUOROACETIC ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HYDROLYSIS; MAJOR DEPRESSION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ACID HYDROLYSIS; MAJOR DEPRESSION; MATRIX-ASSISTED LASER DESORPTION IONIZATION/TIME-OF-FLIGHT MASS SPECTROMETRY; PRINCIPLE COMPONENT ANALYSIS; PROTEIN BIOMARKER;

ADULT; AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; COUMARIC ACIDS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYDROLYSIS; MALE; MIDDLE AGED; PEPTIDES; PRINCIPAL COMPONENT ANALYSIS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRIFLUOROACETIC ACID; YOUNG ADULT;

EID: 84880252625     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.06.003     Document Type: Article

References (37)

1. Khawaja X., Xu J., Liang J.J., Barrett J.E. Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: implications for depressive disorders and future therapies. J Neurosci Res 2004, 75:451-460.
2. Maes M., Lambrechts J., Bosmans E., et al. Evidence for a systemic immune activation during depression - results of leukocyte enumeration by flow-cytometry in conjunction with monoclonal-antibody staining. Psychol Med 1992, 22:45-53.
3. Maes M., Scharpe S., Van Grootel L., et al. Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 1992, 24:183-192.
4. Maes M. Evidence for an immune-response in major depression - a review and hypothesis. Prog Neuropsychopharmacol 1995, 19:11-38.
5. HornigRohan M., Goodman D.B., Kamoun M., Amsterdam J.D. Immune dysfunction in affective subtypes. Biol Psychiatry 1996, 39:524-524.
6. Sluzewska A., Rybakowski J., Bosmans E., et al. Indicators of immune activation in major depression. Psychiatry Res 1996, 64:161-167.
7. Leonard B.E. The HPA, and immune axes in stress: the involvement of the serotonergic system. Eur Psychiatry 2005, 20:S302-S306.
8. Shimoda K., Yamada N., Ohi K., Tsujimoto T., Takahashi K., Takahashi S. Chronic administration of tricyclic antidepressants suppresses hypothalamo-pituitary-adrenocortical activity in male-rats. Psychoneuroendocrinology 1988, 13:431-440.
9. Leonard B.E. Psychopathology of depression. Drugs Today (Barc) 2007, 43:705-716.
10. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:804-815.
11. Meyer J.H., Ginovart N., Boovariwala A., et al. Elevated monoamine oxidase A levels in the brain - an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006, 63:1209-1216.
12. Huang T.L., Wu S.C., Chiang Y.S., Chen J.F. Correlation between serum lipid, lipoprotein concentrations and anxious state, depressive state or major depressive disorder. Psychiatry Res 2003, 118:147-153.
13. Huang T.L., Chen J.F. Lipid and lipoprotein levels in depressive disorders with melancholic feature or atypical feature and dysthymia. Psychiatry Clin Neurosci 2004, 58:295-299.
14. Huang T.L., Chen J.F. Cholesterol and lipids in depression: stress, hypothalamo-pituitary-adrenocortical axis, and inflammation/immunity. Adv Clin Chem 2005, 39:81-105.
15. Huang T.L., Lee C.T., Liu Y.L. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res 2008, 42:521-525.
16. Tsai S.J. The possible role of tissue-type plasminogen activator and the plasminogen system in the pathogenesis of major depression. Med Hypotheses 2006, 66:319-322.
17. Anderson N.L., Anderson N.G. The human plasma proteome - history, character, and diagnostic prospects. Mol Cell Proteomics 2002, 1:845-867.
18. Hortin G.L. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 2006, 52:1223-1237.
19. Coligan J.E., Dunn B.M., Ploegh H.L., Speicher D.W., Wingfield P.T. Current protocols in protein science 1998, 8.0.1-8.6.12. John Wiley & Sons, New York.
20. Harris E.L.V., Angal S. Protein purification methods. A practical approach series 1990, 175-306. IRL Press, Oxford England.
21. Lo L.H., Huang T.L., Shiea J. Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression. Rapid Commun Mass Spectrom 2009, 23:589-598.
22. Maes M., Delange J., Ranjan R., et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 1997, 66:1-11.
23. Vaccarino V., Brennan M.L., Miller A.H., et al. Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study. Biol Psychiatry 2008, 64:476-483.
24. Bremmer M.A., Beekman A.T., Deeg D.J., et al. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 2008, 106:249-255.
25. Rothermundt M., Arolt V., Peters M., et al. Inflammatory markers in major depression and melancholia. J Affect Disord 2001, 63:93-102.
26. Penninx B.W., Kritchevsky S.B., Yaffe K., et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry 2003, 54:566-572.
27. Maes M., Smith R., Christophe A., et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand 1997, 95:212-221.
28. Hornig M., Goodman D.B., Kamoun M., Amsterdam J.D. Positive and negative acute phase proteins in affective subtypes. J Affect Disord 1998, 49:9-18.
29. Maes M., Van de Vyvere J., Vandoolaeghe E., et al. Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. J Affect Disord 1996, 40:23-33.
30. Slotta D.J., Heath L.S., Ramakrishnan N., Helm R., Potts M. Clustering mass spectrometry data using order statistics. Proteomics 2003, 3:1687-1691.
31. Idborg H., Edlund P.O., Jacobsson S.P. Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data. Rapid Commun Mass Spectrom 2004, 18:944-954.
32. Qian J., Cutler J.E., Cole R.B., Cai Y. MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal Bioanal Chem 2008, 392:439-449.
33. Chen P., Lu Y., Harrington P.B. Biomarker profiling and reproducibility study of MALDI-MS measurements of Escherichia coli by analysis of variance-principal component analysis. Anal Chem 2008, 80:1474-1481.
34. Kang S., Shim H.S., Lee J.S., et al. Molecular proteomics imaging of tumor interfaces by mass spectrometry. J Proteome Res 2010, 9:1157-1164.
35. Yao I., Sugiura Y., Matsumoto M., Setou M. In situ proteomics with imaging mass spectrometry and principal component analysis in the Scrapper-knockout mouse brain. Proteomics 2008, 8:3692-3701.
36. Dunn W.B., Bailey N.J.C., Johnson H.E. Measuring the metabolome: current analytical technologies. Analyst 2005, 130:606-625.
37. Mei H., Hsieh Y.S., Nardo C., et al. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. Rapid Commun Mass Spectrom 2003, 17:97-103.